Evidence map›Paper›PMID 33055262›Full record

ArticlemSphere2020

The Two-Component Response Regulator Ssk1 and the Mitogen-Activated Protein Kinase Hog1 Control Antifungal Drug Resistance and Cell Wall Architecture of Candida auris.

Raju Shivarathri, Sabrina Jenull, Anton Stoiber, Manju Chauhan, Rounik Mazumdar, Ashutosh Singh, Filomena Nogueira, Karl Kuchler, Anuradha Chowdhary, Neeraj Chauhan

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
0.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Microbiology and molecular biology reviews : MMBR · 2026
    Review
  8. UnderstandingJournal of medical microbiology · 2026
    Review
  9. Review
  10. Review
  11. Resistance gene mutations and phylogenetic relationships inFrontiers in cellular and infection microbiology · 2026
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Microorganisms · 2025
    Review
  17. Article
  18. Interactions of the emerging fungusMicrobiology spectrum · 2025
    Article
  19. Review
  20. The multidrug-resistantCurrent research in microbial sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Raju ShivarathriPublic Health Research Institute, Rutgers, The State University of New Jersey, Newark, New Jersey, USA.
Sabrina JenullMedical University of Vienna, Department of Medical Biochemistry, Max Perutz Labs Vienna, Vienna, Austria.
Anton StoiberMedical University of Vienna, Department of Medical Biochemistry, Max Perutz Labs Vienna, Vienna, Austria.
Manju ChauhanPublic Health Research Institute, Rutgers, The State University of New Jersey, Newark, New Jersey, USA.
Rounik MazumdarMedical University of Vienna, Department of Medical Biochemistry, Max Perutz Labs Vienna, Vienna, Austria.
Ashutosh SinghDepartment of Medical Mycology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India.
Filomena NogueiraMedical University of Vienna, Department of Medical Biochemistry, Max Perutz Labs Vienna, Vienna, Austria.
Karl KuchlerMedical University of Vienna, Department of Medical Biochemistry, Max Perutz Labs Vienna, Vienna, Austria karl.kuchler@meduniwien.ac.at dranuradha@hotmail.com chauhan1@njms.rutgers.edu.ORCID 0000-0003-2719-5955
Anuradha ChowdharyDepartment of Medical Mycology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India karl.kuchler@meduniwien.ac.at dranuradha@hotmail.com chauhan1@njms.rutgers.edu.ORCID 0000-0002-2028-7462
Neeraj ChauhanPublic Health Research Institute, Rutgers, The State University of New Jersey, Newark, New Jersey, USA karl.kuchler@meduniwien.ac.at dranuradha@hotmail.com chauhan1@njms.rutgers.edu.ORCID 0000-0002-9252-9897
Max Perutz Labs · ATRutgers, The State University of New Jersey · USUniversity of Delhi · IN

Funding

The Candida albicans acetylome in fungal virulenceR01AI124499 · NIAID · RBHS-NEW JERSEY MEDICAL SCHOOL · PI CHAUHAN, NEERAJ · 2016 to 2019
$1.6M
Austrian Science Fund FWF P 33425NIAID NIH HHS R01 AI124499
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adaptation, PhysiologicalAntifungal AgentsCandidaCandidiasisCell WallDrug Resistance, Multiple, FungalFungal ProteinsHumansMicrobial Sensitivity TestsMitogen-Activated Protein KinasesVirulenceAntifungal AgentsFungal ProteinsMitogen-Activated Protein Kinasesamphotericin BCandida auriscaspofungincell wallHOG1MAPK signalingmultidrug resistanceSSK1stress response

Identifiers

PMID33055262
PMCPMC7565899
OpenAlexW3092887456

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.